Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing for HER2 in breast cancer.

F Lewis1, P Jackson, S Lane

  • 1Academic Unit of Pathology, University of Leeds, Leeds, UK.

Histopathology
|August 28, 2004
PubMed
Summary

Accurate human epidermal growth factor receptor 2 (HER2) testing is crucial for effective breast cancer treatment with targeted therapies like Trastuzumab. Laboratories must ensure high throughput and quality assurance for reliable HER2 assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary incontinence and female genital lichen sclerosus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Randomised Badger Culling Trial lacks evidence for proactive badger culling effect on tuberculosis in cattle: comment on Mills et al. 2024, Parts I & II.

bioRxiv : the preprint server for biology·2024
Same author

Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus.

Orphanet journal of rare diseases·2023
Same author

Laser therapy for genital lichen sclerosus: A systematic review of the current evidence base.

Skin health and disease·2022
Same author

2021 European guideline for the management of vulval conditions.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Vulval acne: a case series describing clinical features and management.

Clinical and experimental dermatology·2020

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • Human epidermal growth factor receptor 2 (HER2) is a key molecular target in breast cancer therapy.
  • Targeted therapies like Trastuzumab (Herceptin) efficacy relies on precise HER2 assessment.

Purpose of the Study:

  • To highlight the importance of accurate HER2 assessment in breast cancer treatment.
  • To discuss the challenges and strategies for reliable HER2 testing in laboratories.

Main Methods:

  • Immunohistochemistry and molecular biological techniques are employed for HER2 determination.
  • External quality assurance schemes are essential for validating laboratory performance.
  • Fluorescence in-situ hybridization (FISH) is a critical but challenging testing method.

Related Experiment Videos

Main Results:

  • Reproducible and measurable HER2 assessment requires specialized skills and contextual knowledge.
  • High test throughput and participation in quality assurance programs are vital for laboratories.
  • Various testing strategies exist for HER2, with FISH presenting specific challenges.

Conclusions:

  • Accurate HER2 testing is fundamental for guiding breast cancer targeted therapies.
  • Continuous quality improvement and adherence to established protocols are necessary.
  • Future advancements in rapid techniques like real-time quantitative polymerase chain reaction (rqPCR) and tissue microarrays promise cost and scale efficiencies.